PCA
EW icon

Pallas Capital Advisors’s Edwards Lifesciences EW Stock Holding History

Pallas Capital Advisors’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$363K Sell
4,015
-3,876
-49% -$325K 0.01% 681
2026
Q1 		$632K Sell
7,891
-1,929
-20% -$159K 0.02% 438
2025
Q4 		$837K Sell
9,820
-128
-1% -$10.5K 0.03% 396
2025
Q3 		$774K Buy
9,948
+5,996
+152% +$468K 0.03% 402
2025
Q2 		$309K Buy
3,952
+884
+29% +$65.9K 0.01% 638
2025
Q1 		$222K Buy
+3,068
New +$220K 0.01% 663

Other funds holding EW

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
DZ Bank
DZ Bank Frankfurt Am Main, Germany $130B AUM 46.38% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Pallas Capital Advisors's EW Position: Q2 2026 in Review

Pallas Capital Advisors reduced its Edwards Lifesciences (EW) stake by 49% in Q2 2026, selling an estimated $325K and leaving 4,015 shares worth $363K. The position accounts for 0.01% of the portfolio, ranked #681.

Pallas Capital Advisors first reported a position in EW in Q1 2025 and has held it in 6 quarters since. The position peaked at $837K in Q4 2025. 1,338 funds tracked by Wall St. Rank hold EW as of Q2 2026.

  • Pallas Capital Advisors held 4,015 shares of Edwards Lifesciences worth $363K as of Q2 2026.
  • Pallas Capital Advisors sold 3,876 Edwards Lifesciences shares in Q2 2026, an estimated $325K.
  • Edwards Lifesciences made up 0.01% of Pallas Capital Advisors's portfolio in Q2 2026, its #681 holding.
  • Pallas Capital Advisors first reported a position in Edwards Lifesciences in Q1 2025 and has held it in 6 quarters since.
  • Pallas Capital Advisors's Edwards Lifesciences position peaked at $837K in Q4 2025.
  • 1,338 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on Pallas Capital Advisors's 13F filing for Q2 2026, filed 7 Aug 2026.